This company has been acquired

How has Richard Ashworth's remuneration changed compared to Tivity Health's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2022	n/a	n/a	US$88m
Dec 31 2021	US$2m	US$900k	US$107m
Sep 30 2021	n/a	n/a	US$147m
Jun 30 2021	n/a	n/a	US$60m
Mar 31 2021	n/a	n/a	US$69m
Dec 31 2020	US$12m	US$421k	US$57m

Compensation vs Market: Richard's total compensation ($USD1.95M) is below average for companies of similar size in the US market ($USD5.57M).

Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.

CEO

Richard Ashworth (46 yo)

2yrs

Tenure

US$1,947,673

Compensation

Mr. Richard M. Ashworth serves as President, Chief Executive Officer and Director at Tivity Health, Inc. since June 1, 2020. He has been Director at Free Market Health, Inc. He served as President of Walgr...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Richard Ashworth	President	2yrs	US$1.95m	0.91% $ 14.8m
Adam Holland	Chief Financial Officer	5yrs	US$1.33m	0.14% $ 2.2m
Thomas Lewis	Executive VP & COO	2.5yrs	US$1.15m	0.089% $ 1.4m
Ryan Wagers	Chief Accounting Officer & Controller	3.7yrs	US$620.57k	0.043% $ 700.4k
Joseph Bilbao	Chief Legal Officer & Corporate Secretary	1.5yrs	US$732.03k	0.036% $ 592.2k
Sarah Richardson	Chief Digital & Information Officer	1.2yrs	no data	no data
Matt Milanovich	VP of Investor Relations	no data	no data	no data
Jill Meyer	Vice President of Corporate Communications	no data	no data	no data
Jeremy Kunicki	Senior Vice President of Corporate Development	no data	no data	no data
Bonnie Schirato	Chief People & Culture Officer	no data	no data	no data
Chris Morrison	Senior Vice President of Strategic Management	no data	no data	no data
Jessica Erb	Senior Vice President of Client Relations	no data	no data	no data

2.3yrs

Average Tenure

46yo

Average Age

Experienced Management: TVTY's management team is considered experienced (2.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Richard Ashworth	President	2yrs	US$1.95m	0.91% $ 14.8m
Bradley Karro	Independent Director	8yrs	US$213.83k	0.098% $ 1.6m
Sara Finley	Independent Director	4.1yrs	US$213.83k	0.062% $ 1.0m
Anthony Sanfilippo	Independent Chairman	2.3yrs	US$294.20k	no data
Erin Russell	Independent Director	2.3yrs	US$230.00k	0.052% $ 851.3k
Robert Greczyn	Director	7.1yrs	US$210.75k	0.16% $ 2.6m
Beth Jacob	Independent Director	4.1yrs	US$215.75k	0.055% $ 889.9k
Caroline Apovian	Member of Scientific Advisory Board	2.5yrs	no data	no data
Jay Satz	Member of Scientific Advisory Board	2.5yrs	no data	no data
Arthur Agatston	Member of Scientific Advisory Board	2.5yrs	no data	no data
Ted Kyle	Member of Scientific Advisory Board	2.5yrs	no data	no data
Sandro Galea	Member of Scientific Advisory Board	2.5yrs	no data	no data

2.5yrs

Average Tenure

59yo

Average Age

Experienced Board: TVTY's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

This company has been acquired

Tivity Health Management

Management criteria checks 3/4

Key information

Recent management updates

High number of new and inexperienced directors

Director recently sold US$997k worth of stock

Insider recently bought US$3.5m worth of stock

Read This Before Selling Tivity Health, Inc. (NASDAQ:TVTY) Shares

Tivity Health, Inc. Enters into Separation Agreement and General Release Agreement with Mary Flipse as Chief Legal and Administrative Officer

Recent updates

Tivity Health, Inc.(NasdaqGS:TVTY) dropped from NASDAQ Composite Index

Funds managed by Stone Point Capital LLC completed the acquisition of Tivity Health, Inc. (NasdaqGS:TVTY).

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new and inexperienced directors

Stone Point Capital LLC entered into a definitive agreement to acquire Tivity Health, Inc. (NasdaqGS:TVTY) for $1.6 billion.

Stone Point Capital LLC entered into a definitive agreement to acquire Tivity Health, Inc. (NasdaqGS:TVTY) for $1.6 billion.

We Think Tivity Health (NASDAQ:TVTY) Can Stay On Top Of Its Debt

Full year 2021 earnings: EPS misses analyst expectations

Price target increased to US$30.25

Tivity Health, Inc. Announces Financial Guidance for Fiscal Year Ending December 31, 2022

Tivity Health, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Should You Be Adding Tivity Health (NASDAQ:TVTY) To Your Watchlist Today?

Does Tivity Health (NASDAQ:TVTY) Have A Healthy Balance Sheet?

Director recently sold US$997k worth of stock

Price target increased to US$29.40

Third quarter 2021 earnings released: EPS US$2.09 (vs US$0.87 loss in 3Q 2020)

Tivity Health, Inc. (NasdaqGS:TVTY) announces an Equity Buyback for $100 million worth of its shares.

A Look At The Fair Value Of Tivity Health, Inc. (NASDAQ:TVTY)

Reassessing Tivity Health After Shares' Huge Move Off Pandemic Low

Insider recently bought US$3.5m worth of stock

Consensus forecasts updated

Second quarter 2021 earnings released: EPS US$0.18 (vs US$0.58 in 2Q 2020)

Tivity Health, Inc. Provides Revenue Guidance for the Year 2022

Are Investors Undervaluing Tivity Health, Inc. (NASDAQ:TVTY) By 47%?

These 4 Measures Indicate That Tivity Health (NASDAQ:TVTY) Is Using Debt Reasonably Well

First quarter 2021 earnings released: EPS US$0.41 (vs US$4.08 loss in 1Q 2020)

Tivity Health, Inc. Updates Financial Guidance for the Year 2021

A Look At The Fair Value Of Tivity Health, Inc. (NASDAQ:TVTY)

Full year 2020 earnings released: EPS US$1.17 (vs US$6.17 loss in FY 2019)

Price target raised to US$24.20

Tivity Health, Inc. to Report Q4, 2020 Results on Feb 24, 2021

We Think Tivity Health (NASDAQ:TVTY) Is Taking Some Risk With Its Debt

New 90-day high: US$22.52

Investors Who Bought Tivity Health (NASDAQ:TVTY) Shares Five Years Ago Are Now Up 67%

Cohen Milstein Announces Pendency of Class Action Involving Purchasers of Tivity Health Common Stock

New 90-day high: US$19.85

Read This Before Selling Tivity Health, Inc. (NASDAQ:TVTY) Shares

New 90-day high: US$17.62

Analysts lower EPS estimates to -US$4.04

Tivity Health, Inc. Provides Update on Proposed Settlement of the Claims

Revenue beats expectations, earnings disappoint

Third quarter 2020 earnings released: US$0.87 loss per share

Price target raised to US$20.43

Tivity Health EPS beats by $0.35, beats on revenue

Tivity Health, Inc. Enters into Separation Agreement and General Release Agreement with Mary Flipse as Chief Legal and Administrative Officer

Kainos Capital LP entered into stock purchase agreement to acquire Nutrisystem, Inc. from Tivity Health, Inc. (NasdaqGS:TVTY) for approximately $580 million.

Tivity Health, Inc. Not to Provide Financial Guidance for the Year 2020

New 90-day high - US$17.10

Price target raised to US$18.94

First half earnings released

Tivity Health, Inc. to Report Q2, 2020 Results on Aug 05, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age